Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets

NCT01924767 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: BI 10773 Placebo
DRUG: BI 10773
DRUG: BI 10773 Placebo
DRUG: BI 10773
DRUG: BI 10773 Placebo
DRUG: BI 10773 Placebo
DRUG: BI 10773
DRUG: BI 10773

Sponsor

Boehringer Ingelheim